Optiver Holding’s Cardlytics CDLX Stock Holding History

Optiver Holding’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$29	–	2542
2025 Q3	$29	Buy	+1	New	+$17	﹤0.01%	2635

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Optiver Holding's CDLX Position: Q4 2025 in Review

Optiver Holding sold out of Cardlytics (CDLX) in Q4 2025, closing a stake of 1 share — an estimated $29 sold.

Optiver Holding first reported a position in CDLX in Q3 2025 and held it in 1 quarter. The position peaked at $29 in Q3 2025. 70 funds tracked by Wall St. Rank hold CDLX as of Q4 2025.

Optiver Holding reported no remaining Cardlytics position as of Q4 2025 after selling out during the quarter.
Optiver Holding sold 1 Cardlytics share in Q4 2025, an estimated $29.
Optiver Holding first reported a position in Cardlytics in Q3 2025 and held it in 1 quarter.
Optiver Holding's Cardlytics position peaked at $29 in Q3 2025.
70 funds tracked by Wall St. Rank held Cardlytics as of Q4 2025.

Based on Optiver Holding's 13F filing for Q4 2025, filed 17 Feb 2026.